Lobe Sciences Ltd. (CSE: LOBE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0200
-0.0100 (-33.33%)
Jan 20, 2025, 12:53 PM EST
0.00%
Market Cap 4.58M
Revenue (ttm) 136.21K
Net Income (ttm) -4.42M
Shares Out 183.24M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 26,292
Open 0.0200
Previous Close 0.0300
Day's Range 0.0200 - 0.0200
52-Week Range 0.0100 - 0.0350
Beta 2.00
RSI 51.51
Earnings Date Jan 24, 2025

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol LOBE
Full Company Profile

Financial Performance

In 2024, Lobe Sciences's revenue was 136,205, a decrease of -83.80% compared to the previous year's 840,534. Losses were -4.42 million, -6.09% less than in 2023.

Financial Statements

News

There is no news available yet.